Macular blood flow changes in dysthyroid optic neuropathy after high-dose intravenous pulse methylprednisolone (IVMP)

被引:1
|
作者
Fan, Shu-xian [1 ]
Liang, Jia-qi [1 ]
Wang, Jing [1 ]
Zhou, Chong [1 ]
Zhou, Shi-you [2 ]
Wang, Mei [1 ]
Zeng, Peng [1 ]
机构
[1] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Ophthalmol, 107 West Yanjiang Rd, Guangzhou 510120, Peoples R China
[2] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Peoples R China
关键词
Dysthyroid optic neuropathy; Methylprednisolone; Macula; Vessel densities; Optical coherence tomography angiography; GRAVES ORBITOPATHY EUGOGO; EUROPEAN GROUP; MANAGEMENT; GUIDELINES; PERFUSION; DENSITY;
D O I
10.1016/j.pdpdt.2023.103935
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the changes in macular vessel density (VD) of the superficial layer of retina (SLR) and deep layer of retina (DLR) in dysthyroid optic neuropathy (DON) after high-dose intravenous pulse methyl-prednisolone (IVMP). Materials and Methods: Eighteen DON patients (29 eyes) who completed high-dose IVMP and 16 healthy in-dividuals (32 eyes) were enrolled in this study. Optical coherence tomography angiography (OCTA) image analysis and comprehensive ophthalmic examinations were performed, including the SLR macular whole-image VD (SLR-mwiVD) and DLR-mwiVD, best-corrected visual acuity (BCVA), the mean deviation of visual field (VF-MD), pattern standard deviation of visual field (VF-PSD) and the other parameters.Results: The SLR-mwiVD (41.39 +/- 4.71 vs. 48.13 +/- 3.68, p < 0.001) and DLR-mwiVD (40.77 +/- 5.85 vs. 49.14 +/- 7.02, p < 0.001) were decreased in DON compared to control eyes. After IVMP, visual function parameters were improved, and SLR-mwiVD (49.41 +/- 3.18, p < 0.001) and DLR-mwiVD (50.41 +/- 4.04, p < 0.001) were increased in the DON group compared to pretreatment. The increased SLR-mwiVD and DLR-mwiVD were significantly correlated with improvements in BCVA (Log MAR: from 0.62 +/- 0.49 to-0.01 +/- 0.03, p < 0.001), VF-MD (from - 6.89 +/- 2.89 dB to - 1.75 +/- 1.29 dB, p < 0.001) and VF-PSD (from 4.38 +/- 2.52 dB to 2.32 +/- 1.64 dB, p < 0.001).Conclusion: The increase in macular VD was significantly correlated with the improvement in visual function in DON after IVMP. Macular VD changes on OCTA may be a useful indicator for the response in DON after IVMP.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] High-dose intravenous methylprednisolone in recent traumatic optic neuropathy; a randomized double-masked placebo-controlled clinical trial
    Entezari, Morteza
    Rajavi, Zhaleh
    Sedighi, Neda
    Daftarian, Narssis
    Sanagoo, Masoumeh
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (09) : 1267 - 1271
  • [22] Successful recovery after high-dose intravenous methylprednisolone in acute hemorrhagic leukoencephalitis
    Meilof, JF
    Hijdra, A
    Vermeulen, M
    JOURNAL OF NEUROLOGY, 2001, 248 (10) : 898 - 899
  • [23] Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome
    Pelewicz, Maryla
    Rymuza, Joanna
    Pelewicz, Katarzyna
    Miskiewicz, Piotr
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (08)
  • [24] Successful recovery after high-dose intravenous methylprednisolone in acute hemorrhagic leukoencephalitis
    J. F. Meilof
    A. Hijdra
    M. Vermeulen
    Journal of Neurology, 2001, 248 : 898 - 899
  • [25] High-dose intravenous pulse steroid therapy for optic disc swelling and subretinal fluid in non-arteritic anterior ischemic optic neuropathy
    Takayama, Kei
    Kaneko, Hiroki
    Kachi, Shu
    Ra, Eimei
    Ito, Yasuki
    Terasaki, Hiroko
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2017, 79 (01): : 103 - 108
  • [26] Side-effects of high-dose intravenous (pulse) methylprednisolone therapy cured by potassium infusion
    Bonnotte, B
    Chauffert, B
    Martin, F
    Lorcerie, B
    BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (01): : 109 - 109
  • [27] CLINICAL EFFICACY OF HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    KIMBERLY, R
    LOCKSHIN, M
    SHERMAN, R
    MCDOUGAL, JS
    INMAN, R
    CHRISTIAN, CL
    ARTHRITIS AND RHEUMATISM, 1979, 22 (06): : 629 - 629
  • [28] Cerebral volume changes in multiple sclerosis patients treated with high-dose intravenous methylprednisolone
    Hoogervorst, ELJ
    Polman, C
    Barkhof, F
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (05) : 415 - 419
  • [29] HIGH-DOSE INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY IN PATIENTS WITH RHEUMATOID DISEASE - PLASMA METHYLPREDNISOLONE LEVELS AND ADRENAL-FUNCTION
    BAYLIS, EM
    WILLIAMS, IA
    ENGLISH, J
    MARKS, V
    CHAKRABORTY, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) : 385 - 388
  • [30] Acute hepatitis after high-dose intravenous methylprednisolone pulse therapy in a female relapsing-remitting multiple sclerosis patient
    Reub, R.
    Retzlaff, K.
    Vogel, S.
    Oschmann, P.
    MULTIPLE SCLEROSIS, 2006, 12 : S214 - S214